Achieve Life Sciences

Contributing Author

Recent Articles by Achieve Life Sciences

Jun-26	Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering ACHV -36.47% GlobeNewswire
Jun-26	Achieve Life Sciences Announces Proposed Underwritten Public Offering ACHV GlobeNewswire
Jun-26	Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades ACHV GlobeNewswire
Jun-26	Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation ACHV GlobeNewswire
May-28	Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference ACHV GlobeNewswire
May-20	Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake ACHV GlobeNewswire
May-13	Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program ACHV GlobeNewswire
May-06	Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 ACHV GlobeNewswire